6,750 Shares in Church & Dwight Co., Inc. (NYSE:CHD) Purchased by SVB Wealth LLC

SVB Wealth LLC purchased a new position in Church & Dwight Co., Inc. (NYSE:CHD) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 6,750 shares of the company’s stock, valued at approximately $707,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. State Street Corp raised its position in shares of Church & Dwight by 8.0% during the third quarter. State Street Corp now owns 13,116,334 shares of the company’s stock valued at $1,373,542,000 after buying an additional 969,006 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in Church & Dwight by 5.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 8,016,345 shares of the company’s stock valued at $839,472,000 after acquiring an additional 429,863 shares in the last quarter. Stifel Financial Corp increased its holdings in Church & Dwight by 0.5% in the 3rd quarter. Stifel Financial Corp now owns 4,295,527 shares of the company’s stock valued at $449,830,000 after acquiring an additional 21,607 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Church & Dwight by 1.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,399,502 shares of the company’s stock worth $146,556,000 after purchasing an additional 16,257 shares in the last quarter. Finally, Barclays PLC boosted its holdings in shares of Church & Dwight by 63.9% during the 3rd quarter. Barclays PLC now owns 1,106,131 shares of the company’s stock valued at $115,832,000 after purchasing an additional 431,257 shares during the last quarter. 86.60% of the stock is currently owned by institutional investors.

Church & Dwight Stock Performance

Shares of NYSE:CHD opened at $112.00 on Tuesday. The company has a current ratio of 1.70, a quick ratio of 1.24 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $27.55 billion, a price-to-earnings ratio of 47.26, a PEG ratio of 3.32 and a beta of 0.59. Church & Dwight Co., Inc. has a 12 month low of $96.35 and a 12 month high of $113.50. The firm’s 50-day moving average is $105.84 and its 200 day moving average is $105.12.

Church & Dwight (NYSE:CHD) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.77 earnings per share for the quarter, hitting the consensus estimate of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same period in the prior year, the business earned $0.65 EPS. Research analysts predict that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Friday, February 14th were paid a dividend of $0.295 per share. This is a positive change from Church & Dwight’s previous quarterly dividend of $0.28. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date of this dividend was Friday, February 14th. Church & Dwight’s payout ratio is currently 49.79%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CHD. JPMorgan Chase & Co. reduced their target price on Church & Dwight from $107.00 to $106.00 and set an “underweight” rating on the stock in a report on Friday, February 21st. Truist Financial lifted their price objective on Church & Dwight from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and set a $105.00 target price on shares of Church & Dwight in a research report on Monday, February 3rd. TD Cowen boosted their price target on shares of Church & Dwight from $114.00 to $117.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Church & Dwight from $114.00 to $115.00 and gave the company a “buy” rating in a research report on Monday, November 4th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $111.56.

Insider Transactions at Church & Dwight

In related news, Director Ravichandra Krishnamu Saligram sold 10,000 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $106.11, for a total value of $1,061,100.00. Following the transaction, the director now owns 32,500 shares of the company’s stock, valued at $3,448,575. This represents a 23.53 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael Read bought 1,100 shares of the firm’s stock in a transaction on Monday, December 16th. The shares were purchased at an average cost of $106.82 per share, with a total value of $117,502.00. Following the completion of the transaction, the executive vice president now owns 2,505 shares in the company, valued at $267,584.10. This represents a 78.29 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 2.00% of the company’s stock.

Church & Dwight Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.